Table 5.
Covariable | Unadjusted model | P-value | Adjusted model | P-value |
---|---|---|---|---|
HR (95% CI) | HR (95% CI) | |||
Age (yr) | ||||
< 65 | Reference | Reference | ||
≥ 65 | 1.4 (0.8–2.2) | 0.20 | - | |
Schooling | ||||
High | Reference | Reference | ||
Low | 7.3 (1.0–53.3) | 0.05 | 7.6 (1.1–54.7) | 0.04 |
Origin | ||||
Urban | Reference | Reference | ||
Rural | 0.8 (0.5–1.2) | 0.20 | - | 0.19 |
Clinical stage | ||||
Early | Reference | Reference | ||
Advanced | 2.1 (1.1–4.0) | 0.03 | 2.1 (1.2–4.0) | 0.02 |
Metastasis | ||||
Absence | Reference | Reference | ||
Presence | 1.7 (1.02–2.9) | 0.04 | 1.8 (1.1–2.9) | 0.03 |
Treatment 1 | ||||
Without surgery | Reference | Reference | ||
With surgery | 0.9 (0.5–1.7) | 0.81 | - | 0.26 |
Treatment 2 | ||||
With surgery chemotherapy | Reference | Reference | ||
Without surgery chemotherapy | 0.7 (0.4–1.4) | 0.29 | - | 0.09 |